Novavax, Inc.
MX ˙ BMV ˙ US6700024010
SecurityMX:NVAX / Novavax, Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership1,409,446 shares
Latest Disclosed Value $ 11,472,890
Goldman Sachs Group Inc ownership in NVAX / Novavax, Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 1,409,446 shares of Novavax, Inc. (MX:NVAX) valued at $11,472,890 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 1,090,559 shares of Novavax, Inc.. This represents a change in shares of 29.24% during the quarter.

Goldman Sachs Group Inc has a history of taking positions in derivatives of the underlying security (NVAX) in the form of stock options. The firm currently holds call options representing 187,400 of underlying shares valued at $1,525,436 USD and put options representing 187,400 of underlying shares valued at $1,525,436 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NVAX / Novavax, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NOVAVAX CMN 670002401 1,409,446 318,887 29.24 11,473 56.55 0.0013
2026-02-10 2025-12-31 13F NOVAVAX CMN 670002401 1,090,559 301,283 38.17 7,329 7.09 0.0009
2025-11-14 2025-09-30 13F NOVAVAX CMN 670002401 789,276 -17,385 -2.16 6,843 34.68 0.0008
2025-08-14 2025-06-30 13F NOVAVAX CMN 670002401 806,661 -12,599 -1.54 5,082 -3.24 0.0007
2025-06-27 2025-03-31 13F/A-2 NOVAVAX CMN 670002401 819,260 -138,452 -14.46 5,251 -31.81 0.0008
2025-05-16 2025-03-31 13F/A-1 NOVAVAX CMN 670002401 819,260 -138,452 5,251 0.0008
2025-05-09 2025-03-31 13F NOVAVAX CMN 670002401 819,260 -138,452 5,251 0.0008
2025-02-11 2024-12-31 13F NOVAVAX CMN 670002401 957,712 47,978 5.27 7,700 -32.98 0.0012
2024-11-14 2024-09-30 13F NOVAVAX CMN 670002401 909,734 -521,423 -36.43 11,490 -36.59 0.0019
2024-08-13 2024-06-30 13F NOVAVAX CMN 670002401 1,431,157 494,662 52.82 18,118 304.78 0.0031
2024-05-15 2024-03-31 13F NOVAVAX CMN 670002401 936,495 72,761 8.42 4,476 7.99 0.0008
2024-05-14 2023-12-31 13F/A-2 NOVAVAX CMN 670002401 863,734 297,887 52.64 4,146 1.20 0.0008
2024-03-01 2023-12-31 13F/A-1 NOVAVAX CMN 670002401 863,734 297,887 4,146 0.0007
2024-02-13 2023-12-31 13F NOVAVAX CMN 670002401 863,734 297,887 4,146 0.0002
2024-05-15 2023-09-30 13F/A-1 NOVAVAX CMN 670002401 565,847 28,956 5.39 4,097 2.68 0.0009
2023-11-14 2023-09-30 13F NOVAVAX CMN 670002401 565,847 28,956 4,097 0.0008
2024-05-14 2023-06-30 13F/A-1 NOVAVAX CMN 670002401 536,891 -493,950 -47.92 3,989 -44.16 0.0009
2023-08-15 2023-06-30 13F NOVAVAX CMN 670002401 536,891 -493,950 3,989 0.0008
2024-05-14 2023-03-31 13F/A-1 NOVAVAX CMN 670002401 1,030,841 -293,010 -22.13 7,144 -47.51 0.0016
2023-05-11 2023-03-31 13F NOVAVAX CMN 670002401 1,030,841 -293,010 7,144 0.0015
2024-05-14 2022-12-31 13F/A-1 NOVAVAX CMN 670002401 1,323,851 362,393 37.69 13,609 79,952.94 0.0033
2023-02-13 2022-12-31 13F NOVAVAX CMN 670002401 1,323,851 362,393 13,609 0.0030
2024-05-14 2022-09-30 13F/A-1 NOVAVAX CMN 670002401 961,458 346,261 56.28 17 -45.16 0.0044
2022-11-14 2022-09-30 13F NOVAVAX CMN 670002401 961,458 346,261 17,499 0.0040
2024-05-14 2022-06-30 13F/A-2 NOVAVAX CMN 670002401 615,197 126,453 25.87 32 -99.91 0.0079
2022-08-18 2022-06-30 13F/A-1 NOVAVAX CMN 670002401 615,197 126,453 31,640 0.0071
2022-08-15 2022-06-30 13F NOVAVAX CMN 670002401 615,197 126,453 31,640 0.0071
2022-05-16 2022-03-31 13F NOVAVAX CMN 670002401 488,744 132,144 37.06 35,996 -29.44 0.0076
2022-02-17 2021-12-31 13F/A-1 NOVAVAX CMN 670002401 356,600 -19,812 -5.26 51,018 -34.62 0.0101
2022-02-14 2021-12-31 13F NOVAVAX CMN 670002401 356,600 -19,812 51,018 0.0101
2022-01-20 2021-09-30 13F/A-1 NOVAVAX CMN 670002401 376,412 -64,432 -14.62 78,034 -16.63 0.0166
2021-11-10 2021-09-30 13F NOVAVAX CMN 670002401 376,412 -64,432 78,034 0.0165
2021-08-13 2021-06-30 13F NOVAVAX CMN 670002401 440,844 -324,407 -42.39 93,596 -32.54 0.0210
2021-05-17 2021-03-31 13F NOVAVAX CMN 670002401 765,251 207,343 37.16 138,747 123.02 0.0350
2021-02-12 2020-12-31 13F NOVAVAX CMN 670002401 557,908 312,950 127.76 62,212 134.40 0.0160
2020-11-13 2020-09-30 13F NOVAVAX CMN 670002401 244,958 50,220 25.79 26,541 63.52 0.0075
2020-08-12 2020-06-30 13F NOVAVAX CMN 670002401 194,738 18,384 10.42 16,231 577.70 0.0049
2020-05-15 2020-03-31 13F NOVAVAX CMN 670002401 176,354 142,822 425.93 2,395 1,700.75 0.0008
2020-02-14 2019-12-31 13F NOVAVAX CMN 670002401 33,532 -2,255 -6.30 133 -25.70 0.0000
2019-11-14 2019-09-30 13F NOVAVAX CMN 670002401 35,787 -1,717 -4.58 179 -18.64 0.0001
2019-08-14 2019-06-30 13F NOVAVAX CMN 670002401 37,504 -1,434,382 -97.45 220 -72.84 0.0001
2019-05-15 2019-03-31 13F NOVAVAX CMN 670002104 1,471,886 918,242 165.85 810 -20.43 0.0002
2019-02-14 2018-12-31 13F NOVAVAX CMN 670002104 553,644 -52,895 -8.72 1,018 -10.70 0.0003
2018-11-14 2018-09-30 13F NOVAVAX CMN 670002104 606,539 -46,392 -7.11 1,140 30.29 0.0003
2018-08-14 2018-06-30 13F NOVAVAX CMN 670002104 652,931 204,359 45.56 875 -7.11 0.0002
2018-05-15 2018-03-31 13F NOVAVAX CMN 670002104 448,572 180,227 67.16 942 182.88 0.0002
2018-02-14 2017-12-31 13F NOVAVAX CMN 670002104 268,345 -320,326 -54.42 333 -50.37 0.0001
2017-11-14 2017-09-30 13F NOVAVAX CMN 670002104 588,671 121,324 25.96 671 24.95 0.0002
2017-08-14 2017-06-30 13F NOVAVAX CMN 670002104 467,347 -261,443 -35.87 537 -42.44 0.0001
2017-05-18 2017-03-31 13F/A-1 NOVAVAX CMN 670002104 728,790 336,795 85.92 933 88.87 0.0003
2017-05-15 2017-03-31 13F NOVAVAX CMN 670002104 728,790 336,795 933
2017-02-14 2016-12-31 13F NOVAVAX CMN 670002104 391,995 -182,418 -31.76 494 -58.66 0.0001
2016-11-14 2016-09-30 13F NOVAVAX CMN 670002104 574,413 218,551 61.41 1,195 -53.81 0.0004
2016-08-15 2016-06-30 13F NOVAVAX CMN 670002104 355,862 -115,461 -24.50 2,587 6.37 0.0008
2016-05-13 2016-03-31 13F NOVAVAX CMN 670002104 471,323 202,672 75.44 2,432 7.90 0.0008
2016-02-16 2015-12-31 13F NOVAVAX CMN 670002104 268,651 -291,391 -52.03 2,254 -43.07 0.0007
2015-11-13 2015-09-30 13F NOVAVAX CMN 670002104 560,042 354,997 173.13 3,959 73.34 0.0013
2015-08-14 2015-06-30 13F NOVAVAX CMN 670002104 205,045 -168,922 -45.17 2,284 -26.16 0.0007
2015-05-15 2015-03-31 13F NOVAVAX CMN 670002104 373,967 131,287 54.10 3,093 114.94 0.0010
2015-02-13 2014-12-31 13F NOVAVAX CMN 670002104 242,680 106,048 77.62 1,439 152.46 0.0005
2014-11-14 2014-09-30 13F NOVAVAX CMN 670002104 136,632 14,297 11.69 570 0.88 0.0002
2014-08-14 2014-06-30 13F NOVAVAX CMN 670002104 122,335 -421,148 -77.49 565 -77.05 0.0002
2014-05-15 2014-03-31 13F NOVAVAX CMN 670002104 543,483 463,863 582.60 2,462 504.91 0.0008
2014-02-14 2013-12-31 13F NOVAVAX CMN 670002104 79,620 17,141 27.43 407 106.60 0.0001
2013-11-14 2013-09-30 13F NOVAVAX CMN 670002104 62,479 31,019 98.60 197 207.81 0.0001
2013-08-14 2013-06-30 13F NOVAVAX CMN 670002104 31,460 -172,854 -84.60 64 -83.42 0.0000
2013-06-14 2012-12-31 13F/A-1 NOVAVAX CMN 670002104 204,314 159,167 352.55 386 293.88 0.0002
2013-06-14 2012-09-30 13F/A-2 NOVAVAX CMN 670002104 45,147 -1,701 -3.63 98 34.25 0.0000
2013-06-14 2012-06-30 13F/A-2 NOVAVAX CMN 670002104 46,848 -10,779 -18.70 73 0.00 0.0000
2013-06-14 2012-03-31 13F/A-1 NOVAVAX CMN 670002104 57,627 57,627 73 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F NOVAVAX CMN Call 187,400 0.00 1,525 21.13 n/a n/a n/a
2026-02-10 2025-12-31 13F NOVAVAX CMN Call 187,400 0.00 1,259 -22.48 n/a n/a n/a
2025-11-14 2025-09-30 13F NOVAVAX CMN Call 187,400 0.00 1,625 37.63 n/a n/a n/a
2025-08-14 2025-06-30 13F NOVAVAX CMN Call 187,400 1,181 n/a n/a n/a
2025-06-27 2025-03-31 13F/A NOVAVAX CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-16 2025-03-31 13F/A NOVAVAX CMN Call 0 0 n/a n/a n/a
2025-05-09 2025-03-31 13F NOVAVAX CMN Call 0 0 n/a n/a n/a
2025-02-11 2024-12-31 13F NOVAVAX CMN Call 58,800 473 n/a n/a n/a
2022-05-16 2022-03-31 13F NOVAVAX CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-17 2021-12-31 13F/A NOVAVAX CMN Call 26,700 0.00 3,820 -30.98 n/a n/a n/a
2022-02-14 2021-12-31 13F NOVAVAX CMN Call 26,700 3,820 n/a n/a n/a
2022-01-20 2021-09-30 13F/A NOVAVAX CMN Call 26,700 0.00 5,535 -2.36 n/a n/a n/a
2021-11-10 2021-09-30 13F NOVAVAX CMN Call 26,700 5,535 n/a n/a n/a
2021-08-13 2021-06-30 13F NOVAVAX CMN Call 26,700 0.00 5,669 17.10 n/a n/a n/a
2021-05-17 2021-03-31 13F NOVAVAX CMN Call 26,700 3.89 4,841 68.91 n/a n/a n/a
2021-02-12 2020-12-31 13F NOVAVAX CMN Call 25,700 176.34 2,866 184.33 n/a n/a n/a
2020-11-13 2020-09-30 13F NOVAVAX CMN Call 9,300 -63.81 1,008 -64.83 n/a n/a n/a
2020-08-12 2020-06-30 13F NOVAVAX CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F NOVAVAX CMN Call 63,800 866 n/a n/a n/a
2017-05-18 2017-03-31 13F/A NOVAVAX CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F NOVAVAX CMN Call 135,000 -30.77 170 -58.13 n/a n/a n/a
2016-11-14 2016-09-30 13F NOVAVAX CMN Call 195,000 44.44 406 -58.61 n/a n/a n/a
2016-08-15 2016-06-30 13F NOVAVAX CMN Call 135,000 0.00 981 40.75 n/a n/a n/a
2016-05-13 2016-03-31 13F NOVAVAX CMN Call 135,000 -53.38 697 -71.32 n/a n/a n/a
2016-02-16 2015-12-31 13F NOVAVAX CMN Call 289,600 0.00 2,430 18.71 n/a n/a n/a
2015-11-13 2015-09-30 13F NOVAVAX CMN Call 289,600 44.80 2,047 224.92 n/a n/a n/a
2013-11-14 2013-09-30 13F NOVAVAX CMN Call 200,000 -30.94 630 -69.22 n/a n/a n/a
2013-08-14 2013-06-30 13F NOVAVAX CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2013-06-14 2012-12-31 13F/A NOVAVAX CMN Call 2,000,000 3,780 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F NOVAVAX CMN Put 187,400 -4.53 1,525 15.62 n/a n/a n/a
2026-02-10 2025-12-31 13F NOVAVAX CMN Put 196,300 4.75 1,319 -18.78 n/a n/a n/a
2025-11-14 2025-09-30 13F NOVAVAX CMN Put 187,400 0.00 1,625 37.63 n/a n/a n/a
2025-08-14 2025-06-30 13F NOVAVAX CMN Put 187,400 1,181 n/a n/a n/a
2024-11-14 2024-09-30 13F NOVAVAX CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-13 2024-06-30 13F NOVAVAX CMN Put 1,330,700 16,847 n/a n/a n/a
2024-05-14 2023-06-30 13F/A NOVAVAX CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-14 2023-06-30 13F/A NOVAVAX CMN Put 0 0 n/a n/a n/a
2023-08-15 2023-06-30 13F NOVAVAX CMN Put 0 0 n/a n/a n/a
2024-05-14 2023-03-31 13F/A NOVAVAX CMN Put 491,700 881.44 3,407 561.55 n/a n/a n/a
2023-05-11 2023-03-31 13F NOVAVAX CMN Put 491,700 3,407 n/a n/a n/a
2024-05-14 2022-12-31 13F/A NOVAVAX CMN Put 50,100 -82.03 515 10,200.00 n/a n/a n/a
2023-02-13 2022-12-31 13F NOVAVAX CMN Put 50,100 515 n/a n/a n/a
2024-05-14 2022-09-30 13F/A NOVAVAX CMN Put 278,800 174.68 5 0.00 n/a n/a n/a
2022-11-14 2022-09-30 13F NOVAVAX CMN Put 278,800 5,074 n/a n/a n/a
2022-08-18 2022-06-30 13F/A NOVAVAX CMN Put 101,500 5,220 n/a n/a n/a
2024-05-14 2022-06-30 13F/A NOVAVAX CMN Put 101,500 5 n/a n/a n/a
2022-08-15 2022-06-30 13F NOVAVAX CMN Put 101,500 5,220 n/a n/a n/a
2022-05-16 2022-03-31 13F NOVAVAX CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-17 2021-12-31 13F/A NOVAVAX CMN Put 178,900 25,595 n/a n/a n/a
2022-02-14 2021-12-31 13F NOVAVAX CMN Put 178,900 25,595 n/a n/a n/a
2021-05-14 2021-03-31 13F NOVAVAX CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-12 2020-12-31 13F NOVAVAX CMN Put 2,000 -88.70 223 -88.37 n/a n/a n/a
2020-11-13 2020-09-30 13F NOVAVAX CMN Put 17,700 -11.50 1,918 4,466.67 n/a n/a n/a
2016-11-14 2016-09-30 13F NOVAVAX CMN Put 20,000 12.99 42 -97.81 n/a n/a n/a
2016-08-15 2016-06-30 13F NOVAVAX CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-13 2016-03-31 13F NOVAVAX CMN Put 104,600 0.00 540 -38.50 n/a n/a n/a
2016-02-16 2015-12-31 13F NOVAVAX CMN Put 104,600 -33.63 878 -21.18 n/a n/a n/a
2015-11-13 2015-09-30 13F NOVAVAX CMN Put 157,600 1,114 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.